mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging

Area of Science:

• Cellular Biology
• Immunology
• Metabolism

Background:

• The mechanistic target of rapamycin (mTOR) is a kinase regulating cell growth and metabolism.
• mTOR exists in two complexes, mTORC1 and mTORC2, influencing gene transcription, protein translation, and autophagy.
• mTOR is crucial for immune cell lineage specification and metabolic adaptation.

Purpose of the Study:

• To explore the role of mTOR in integrating growth signals and its implications in disease.
• To investigate mTOR's involvement in immune system regulation and metabolic processes.
• To highlight the therapeutic potential of mTOR inhibitors.

Main Methods:

• Literature review and synthesis of existing research on mTOR signaling.
• Analysis of mTOR's role in cellular proliferation, survival, and metabolic pathways.
• Examination of mTOR's involvement in autoimmune diseases, cancer, and metabolic disorders.

Main Results:

• mTORC1 activation is implicated in the pathogenesis of autoimmune diseases like lupus due to oxidative stress.
• mTORC1 mediates the Warburg effect, facilitating cell survival under hypoxic conditions.
• mTOR signaling is a key regulator of immune cell function and metabolic homeostasis.

Conclusions:

• mTOR inhibitors, including rapamycin, are being developed to treat transplant rejection, autoimmunity, obesity, and cancer.
• Targeting mTOR offers a personalized therapeutic strategy with the potential to extend lifespan.
• Understanding mTOR's multifaceted roles is critical for developing novel disease treatments.